Modalis Therapeutics Corporation
Status: Publicly traded
Direct answer
Modalis Therapeutics Corporation is publicly traded on JPX under the ticker 4883.T.
Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to create therapies by controlling gene expression through the epigenetic modulation of specific genetic loci. Modalis also has a collaborative research agreement with JCR Pharmaceuticals Co., Ltd., aimed at assessing gene therapy drug delivery...
Can you invest in Modalis Therapeutics Corporation?
Yes. Modalis Therapeutics Corporation is publicly traded on JPX under the ticker 4883.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Modalis Therapeutics Corporation
Detailed equity research is provided by MarketSnap.